Free Trial
→ [625,000% Gain] – Are You Ready for the Next Altcoin Boom? (From Crypto Swap Profits) (Ad) Free CNCR Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.

Range Cancer Therapeutics ETF (CNCR) Short Interest Ratio & Short Volume

Compare

Range Cancer Therapeutics ETF Short Interest Data

Range Cancer Therapeutics ETF (CNCR) has a short interest of 1,700 shares. This marks a 1,600.00% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 6,668 shares to cover all short positions.

Current Short Interest
1,700 shares
Previous Short Interest
100 shares
Change Vs. Previous Month
+1,600.00%
Dollar Volume Sold Short
$24,786.00
Short Interest Ratio
0.4 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
1,180,000 shares
Percentage of Shares Shorted
0.14%
Today's Trading Volume
1,335 shares
Average Trading Volume
6,668 shares
Today's Volume Vs. Average
20%
Short Selling Range Cancer Therapeutics ETF?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Range Cancer Therapeutics ETF and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

CNCR Short Interest Over Time

CNCR Days to Cover Over Time

CNCR Percentage of Float Shorted Over Time

Range Cancer Therapeutics ETF Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/20241,700 shares $24,786.00 +1,600.0%N/A0.4 $14.58
10/15/2024100 shares $1,506.00 -75.0%N/A0 $15.06
9/30/2024400 shares $5,980.00 -76.5%N/A0.1 $14.95
9/15/20241,700 shares $27,387.00 +1,600.0%N/A0.3 $16.11
8/31/2024100 shares $1,508.00 -94.7%N/A0 $15.08
8/15/20241,900 shares $26,980.00 +5.6%N/A0.3 $14.20
7/31/20241,800 shares $27,540.00 -74.3%N/A0.2 $15.30
7/15/20247,000 shares $107,450.00 +62.8%N/A0.8 $15.35
6/30/20244,300 shares $58,071.50 -42.7%N/A0.3 $13.51
6/15/20247,500 shares $107,025.00 -25.7%N/A0.5 $14.27
5/31/202410,100 shares $146,450.00 -58.9%N/A0.3 $14.50
5/15/202424,600 shares $374,904.00 +748.3%N/A0.7 $15.24
4/30/20242,900 shares $42,804.00 -79.1%N/A0.1 $14.76
4/15/202413,900 shares $208,639.00 -50.2%N/A0.4 $15.01
3/31/202427,900 shares $463,698.00 -59.2%N/A0.8 $16.62
3/15/202468,300 shares $1.11 million +73.4%N/A2.1 $16.26
2/29/202439,400 shares $680,438.00 +47.0%N/A2.6 $17.27
2/15/202426,800 shares $429,738.00 +538.1%N/A2.9 $16.04
1/31/20244,200 shares $59,472.00 No ChangeN/A0.8 $14.16
5/15/2023100 shares $1,374.00 -92.9%N/A0 $13.74
4/30/20231,400 shares $17,707.90 -44.0%N/A0.2 $12.65
4/15/20232,500 shares $31,025.00 +257.1%N/A0.4 $12.41
3/31/2023700 shares $8,393.00 +16.7%N/A0.1 $11.99
3/15/2023600 shares $7,494.00 -78.6%N/A0.2 $12.49
2/28/20232,800 shares $37,660.00 -47.2%N/A0.8 $13.45
2/15/20235,300 shares $75,366.00 -38.4%N/A1.5 $14.22
1/31/20238,600 shares $127,710.00 -4.4%N/A2.5 $14.85
1/15/20239,000 shares $132,750.00 +5.9%N/A1.4 $14.75
12/30/20228,500 shares $116,705.00 -35.6%N/A1.3 $13.73
12/15/202213,200 shares $200,376.00 +12.8%N/A1.4 $15.18
11/30/202211,700 shares $174,447.00 +9.4%N/A1.3 $14.91
11/15/202210,700 shares $165,743.00 -23.0%N/A1.2 $15.49
10/31/202213,900 shares $208,500.00 +0.7%N/A1.5 $15.00
10/15/202213,800 shares $201,894.00 No ChangeN/A2.1 $14.63
9/30/202212,700 shares $183,134.00 -21.1%N/A1.7 $14.42
9/15/202216,100 shares $260,820.00 +3.9%N/A3 $16.20
8/31/202215,500 shares $240,405.00 -15.8%N/A2.2 $15.51
8/15/202218,400 shares $330,832.00 +13.6%N/A2.5 $17.98
7/31/202216,200 shares $259,200.00 -12.0%N/A2.1 $16.00
7/15/202218,400 shares $304,704.00 -27.0%N/A2.4 $16.56
“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad)

Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.

Learn these 4 simple steps and protect your savings before it’s too late.
6/30/202225,200 shares $382,788.00 -2.0%N/A3.8 $15.19
6/15/202225,700 shares $345,022.50 +26.0%N/A3.7 $13.43
5/31/202220,400 shares $283,941.48 +23.6%N/A3.9 $13.92
5/15/202216,500 shares $236,445.00 +17.0%N/A3.4 $14.33
4/30/202214,100 shares $218,225.70 -6.0%N/A3.1 $15.48
4/15/202215,000 shares $264,150.00 -8.5%N/A2.1 $17.61
3/31/202216,400 shares $297,332.00 -13.7%N/A1.9 $18.13
3/15/202219,000 shares $311,790.00 +36.7%N/A2.3 $16.41
2/28/202213,900 shares $255,760.00 -30.5%N/A1.6 $18.40
2/15/202220,000 shares $372,020.00 +48.2%N/A2.2 $18.60
1/31/202213,500 shares $247,847.85 +5.5%N/A1.5 $18.36
1/15/202212,800 shares $261,120.00 +1,728.6%N/A1.9 $20.40
12/31/2021700 shares $17,037.30 -50.0%N/A0.1 $24.34
12/15/20211,400 shares $34,716.36 -6.7%N/A0.3 $24.80
11/30/20211,500 shares $40,320.00 +150.0%N/A0.3 $26.88
11/15/2021600 shares $17,136.00 -14.3%N/A0.1 $28.56
10/29/2021700 shares $20,189.19 +16.7%N/A0.1 $28.84
10/15/2021600 shares $17,514.00 -33.3%N/A0.1 $29.19
9/30/2021900 shares $27,837.00 +50.0%N/A0.2 $30.93
9/15/2021600 shares $18,552.00 No ChangeN/A0.1 $30.92
8/31/2021600 shares $18,336.00 -64.7%N/A0.1 $30.56
8/13/20211,700 shares $48,909.00 No ChangeN/A0.3 $28.77
7/30/20211,700 shares $50,405.00 -48.5%N/A0.3 $29.65
7/15/20213,300 shares $97,350.00 -2.9%N/A0.6 $29.50
6/30/20213,400 shares $108,426.00 +13.3%N/A0.5 $31.89
6/15/20213,000 shares $91,860.00 +11.1%N/A0.4 $30.62
5/28/20212,700 shares $82,593.00 +28.6%N/A0.4 $30.59
5/14/20212,100 shares $60,480.00 +10.5%N/A0.3 $28.80
4/30/20211,900 shares $58,862.00 -74.7%N/A0.3 $30.98
4/15/20217,500 shares $218,250.00 +17.2%N/A1 $29.10
3/31/20216,400 shares $185,920.00 +25.5%N/A0.8 $29.05
3/15/20215,100 shares $163,149.00 No ChangeN/A0.6 $31.99
2/26/20215,100 shares $159,120.00 -60.8%N/A0.5 $31.20
2/12/202113,000 shares $449,686.90 +3.2%N/A1.2 $34.59
1/29/202112,600 shares $411,982.20 +215.0%N/A1.2 $32.70
1/15/20214,000 shares $139,985.20 No ChangeN/A0.4 $35.00

CNCR Short Interest - Frequently Asked Questions

What is Range Cancer Therapeutics ETF's current short interest?

Short interest is the volume of Range Cancer Therapeutics ETF shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 1,700 shares of CNCR short. Learn More on Range Cancer Therapeutics ETF's current short interest.

Is Range Cancer Therapeutics ETF's short interest increasing or decreasing?

Range Cancer Therapeutics ETF saw a increase in short interest in October. As of October 31st, there was short interest totaling 1,700 shares, an increase of 1,600.0% from the previous total of 100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Range Cancer Therapeutics ETF's short interest compare to its competitors?

Here is how the short interest of companies compare to Range Cancer Therapeutics ETF: JPMorgan Healthcare Leaders ETF (1.31%), First Trust Nasdaq Pharmaceuticals ETF (0.48%), ProShares UltraShort Nasdaq Biotechnology (2.95%), Invesco Nasdaq Biotechnology ETF (0.89%), ProShares Ultra Nasdaq Biotechnology (0.55%), Invesco Dorsey Wright Healthcare Momentum ETF (0.03%), Invesco S&P SmallCap Health Care ETF (0.00%), VanEck Biotech ETF (0.02%), VanEck Pharmaceutical ETF (25.17%), and iShares Biotechnology ETF (20.08%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Range Cancer Therapeutics ETF stock?

Short selling CNCR is an investing strategy that aims to generate trading profit from Range Cancer Therapeutics ETF as its price is falling. CNCR shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Range Cancer Therapeutics ETF?

A short squeeze for Range Cancer Therapeutics ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CNCR, which in turn drives the price of the stock up even further.

How often is Range Cancer Therapeutics ETF's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CNCR, twice per month. The most recent reporting period available is October, 31 2024.



Related Companies
Short Interest Tools

This page (NASDAQ:CNCR) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners
The Crypto That’s Making Wall Street Sweat
The Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...
Crypto 101 Media | Sponsored
Missed Nvidia? Watch this ASAP
This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...
Brownstone Research | Sponsored
Musk’s new company could top a trillion?
The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...
Paradigm Press | Sponsored
24/7 Automated Profits in Crypto
What if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...
Crypto Swap Profits | Sponsored
Crypto’s next big bull run?
Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...
Weiss Ratings | Sponsored
“This Changes Everything” - Trump Hands Millions Massive IRS Gift
Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...
Colonial Metals | Sponsored
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...
Timothy Sykes | Sponsored
Elon knows the truth, which is why they want him silenced
Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...
Porter & Company | Sponsored